The arginine-nitric oxide pathway in thrombotic microangiopathy.
about
L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS).Endogenous production of nitric oxide synthase inhibitors.Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants.The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
P2860
The arginine-nitric oxide pathway in thrombotic microangiopathy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@ast
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@en
type
label
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@ast
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@en
prefLabel
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@ast
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@en
P2093
P2860
P1476
The arginine-nitric oxide pathway in thrombotic microangiopathy.
@en
P2093
A Petersson
A Wennmalm
G Westberg
L Sigström
P2860
P304
P356
10.3109/00365599709030646
P577
1997-10-01T00:00:00Z